Zenosense is looking
at developing and marketing a device to be used in healthcare settings to
detect the Methicillin-resistant Staphylococcus aureus (MRSA) “Super-Bug.” The
company’s findings are grabbing the attention of the medical community as noted
in many reputable publications.
ScienceDaily,
reporting on an article in The New England Journal of Medicine about a new
highly-resistant MRSA bacterium, stated University of Texas Health Science
Center’s international research team has identified a new superbug which has
caused an infection in the bloodstream in a patient in Brazil. This case is the
first reported bloodstream infection caused by a highly vancomycin-resistant
MRSA bacteria. Vancomycin is known to be the least expensive antibiotic used for
the treatment of invasive MRSA.
In a U.S. News
article it’s reported that Electronic Cigarette vapor appears to increase the
virulence of MRSA as well. An abstract from a study conducted by the University
of California-San Diego and the VA San Diego Healthcare System claims that MRSA
cells exposed to the e-cigarette vapor in the lungs of mice with pneumonia were
three times more likely to survive than MRSA cells that were not exposed to the
vapor. The lead researcher connected the greater virulence to a change in pH,
causing the MRSA bacteria to become defensive and less vulnerable to attack.
In a CBS News story
the company cites a study showing MRSA is thriving in homes and hospitals and
other healthcare settings. It is being indicated that according to the lead
researcher at Columbia University Medical Center, MRSA is now endemic in
households. Published April 21, 2014 in Proceedings of the National Academy of
Sciences, the findings are based on a study of 161 New York City residents who
contracted MRSA between 2009 and 2011. It was determined that people’s
residences were housing the MRSA strain USA300, which is the leading cause of
community MRSA infections in the U.S.
Zenosense is a
detection device development company based in Valencia, Spain. It centers its
endeavors on developing, marketing and selling an effective MRSA detector
through its licensed technology, for sale to healthcare providers for use in
clinical settings.
For more information
on the company visit www.zenosense.net
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment